Entity Public Float of BriaCell Therapeutics Corp. from 31 Jan 2022 to 31 Jan 2025

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: BriaCell Therapeutics Corp. quarterly Entity Public Float in USD history and change rate from 31 Jan 2022 to 31 Jan 2025.
BriaCell Therapeutics Corp. Entity Public Float for the quarter ending 31 Jan 2025 was $94,477,705, a 48% increase year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$94,477,705	+$30,785,282	+48%	31 Jan 2025	10-K	16 Oct 2025	2025	FY
Q4 2023	$63,692,423	-$41,471,328	-39%	31 Jan 2024	10-K	29 Oct 2024	2024	FY
Q4 2022	$105,163,751	+$16,530,546	+19%	31 Jan 2023	10-K	25 Oct 2023	2023	FY
Q4 2021	$88,633,205			31 Jan 2022	10-K	28 Oct 2022	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.